Initial Treatment for 60-Year-Old Woman with New-Onset Urinary Frequency
Before initiating any treatment, you must first rule out urinary tract infection and determine whether this is urgency-predominant urinary incontinence, stress incontinence, or isolated frequency without incontinence—this distinction fundamentally changes management.
Critical First Step: Establish the Diagnosis
The patient's attribution to "age and hormones" suggests she may have genitourinary syndrome of menopause (GSM), but urinary frequency alone for only 2 weeks requires immediate evaluation for:
- Urinary tract infection (most common reversible cause)
- Metabolic disorders (diabetes, hypercalcemia)
- Medications that worsen urinary symptoms
- Excess fluid intake
- Type of incontinence if present (stress vs. urgency vs. mixed)
If This is Urgency Urinary Incontinence or Overactive Bladder
Start with bladder training as first-line therapy (strong recommendation, moderate-quality evidence). 1 This is behavioral therapy that involves scheduled voiding and progressively extending the time between voids. Bladder training is:
- More effective than medications for many patients
- Free of adverse effects
- Cost-effective
- Specifically recommended for urgency UI
Do NOT start with medications initially. 1
If Bladder Training Fails After 6-8 Weeks
Only then consider pharmacologic therapy. When selecting medications for urgency UI:
- Solifenacin has the lowest discontinuation rate due to adverse effects 1
- Darifenacin and tolterodine have discontinuation rates similar to placebo 1
- Avoid oxybutynin as first-choice—it has the highest discontinuation rate due to adverse effects 1
All antimuscarinics are equally efficacious, so choose based on tolerability profile. 1
If This is Stress Urinary Incontinence
Start with pelvic floor muscle training (PFMT) as first-line treatment (strong recommendation, high-quality evidence). 1
Do NOT use systemic pharmacologic therapy for stress UI—it is ineffective. 1 This is a strong recommendation with low-quality evidence showing no benefit. 1
If This is Mixed Incontinence
Combine PFMT with bladder training (strong recommendation, moderate-quality evidence). 1
The Hormonal Component: GSM Considerations
Given the patient's age (60) and her belief that symptoms relate to hormones, consider genitourinary syndrome of menopause:
If vaginal atrophy is present on examination, offer local low-dose vaginal estrogen. 2, 3, 4 This specifically helps with:
- Urinary frequency
- Urgency
- Dysuria
- Recurrent UTIs
Key distinction: Vaginal estrogen improves urinary symptoms in postmenopausal women, while systemic estrogen may actually worsen urinary incontinence. 4 Local therapy is preferred when only genitourinary symptoms are present. 2
For postmenopausal women with OAB, local low-dose vaginal estrogen can be used as adjunctive therapy and may improve response to other treatments. 2, 5
If Patient is Obese
Recommend weight loss and exercise (strong recommendation, moderate-quality evidence). 1 This improves all types of UI and should be part of the treatment plan regardless of other interventions.
Common Pitfalls to Avoid
- Starting medications before behavioral therapy—this violates guideline recommendations and exposes patients to unnecessary adverse effects 1
- Using systemic estrogen for stress UI—it doesn't work and may worsen symptoms 1, 4
- Prescribing oxybutynin as first-line antimuscarinic—it has the worst tolerability profile 1
- Missing reversible causes like UTI, medications, or metabolic disorders 1
- Failing to examine for vaginal atrophy in a 60-year-old woman—this is a treatable contributor 2, 3
Practical Algorithm
- Rule out UTI with urinalysis
- Perform vaginal examination to assess for atrophy
- Classify the type of UI (stress, urgency, mixed, or frequency without incontinence)
- Start behavioral therapy appropriate to type:
- Urgency → Bladder training
- Stress → PFMT
- Mixed → Both
- Add local vaginal estrogen if GSM present
- Reserve medications for urgency UI that fails behavioral therapy after 6-8 weeks
- Recommend weight loss if BMI ≥25
The patient's stress about symptoms warrants reassurance that effective non-pharmacologic treatments exist with minimal adverse effects, and that improvement typically occurs within 6-8 weeks of consistent behavioral therapy. 1